These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8824696)

  • 1. Effect of oxybutynin on the QTc interval in elderly patients with urinary incontinence.
    Hussain RM; Hartigan-Go K; Thomas SH; Ford GA
    Br J Clin Pharmacol; 1996 Jan; 41(1):73-5. PubMed ID: 8824696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Terodiline causes polymorphic ventricular tachycardia due to reduced heart rate and prolongation of QT interval.
    Stewart DA; Taylor J; Ghosh S; Macphee GJ; Abdullah I; McLenachan JM; Stott DJ
    Eur J Clin Pharmacol; 1992; 42(6):577-80. PubMed ID: 1623896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in the effects of urinary incontinence agents S-oxybutynin and terodiline on cardiac K(+) currents and action potentials.
    Jones SE; Shuba LM; Zhabyeyev P; McCullough JR; McDonald TF
    Br J Pharmacol; 2000 Sep; 131(2):245-54. PubMed ID: 10991917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentration dependent cardiotoxicity of terodiline in patients treated for urinary incontinence.
    Thomas SH; Higham PD; Hartigan-Go K; Kamali F; Wood P; Campbell RW; Ford GA
    Br Heart J; 1995 Jul; 74(1):53-6. PubMed ID: 7662454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxybutynin. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in detrusor instability.
    Yarker YE; Goa KL; Fitton A
    Drugs Aging; 1995 Mar; 6(3):243-62. PubMed ID: 7620236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An extended-release formulation of oxybutynin chloride for the treatment of overactive urinary bladder.
    Goldenberg MM
    Clin Ther; 1999 Apr; 21(4):634-42. PubMed ID: 10363730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the antimuscarinic and antispasmodic actions of racemic oxybutynin and desethyloxybutynin and their enantiomers with those of racemic terodiline.
    Smith ER; Wright SE; Aberg G; Fang Y; McCullough JR
    Arzneimittelforschung; 1998 Oct; 48(10):1012-8. PubMed ID: 9825119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trospium chloride and oxybutynin hydrochloride in a german study of adults with urinary urge incontinence: results of a 12-week, multicenter, randomized, double-blind, parallel-group, flexible-dose noninferiority trial.
    Zellner M; Madersbacher H; Palmtag H; Stöhrer M; Bödeker RH;
    Clin Ther; 2009 Nov; 31(11):2519-39. PubMed ID: 20109997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Terodiline and oxybutynin in detrusor instability.
    Drug Ther Bull; 1988 May; 26(10):37-8. PubMed ID: 3383752
    [No Abstract]   [Full Text] [Related]  

  • 10. The treatment of detrusor instability in post-menopausal women with oxybutynin chloride: a double blind placebo controlled study.
    Tapp AJ; Cardozo LD; Versi E; Cooper D
    Br J Obstet Gynaecol; 1990 Jun; 97(6):521-6. PubMed ID: 2198921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxybutynin chloride for geriatric urinary dysfunction: a double-blind placebo-controlled study.
    Zorzitto ML; Holliday PJ; Jewett MA; Herschorn S; Fernie GR
    Age Ageing; 1989 May; 18(3):195-200. PubMed ID: 2675580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative characterization of therapeutic index: application of mixed-effects modeling to evaluate oxybutynin dose-efficacy and dose-side effect relationships.
    Gupta SK; Sathyan G; Lindemulder EA; Ho PL; Sheiner LB; Aarons L
    Clin Pharmacol Ther; 1999 Jun; 65(6):672-84. PubMed ID: 10391673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and clinical effects of oxybutynin in geriatric patients.
    Ouslander JG; Blaustein J; Connor A; Orzeck S; Yong CL
    J Urol; 1988 Jul; 140(1):47-50. PubMed ID: 3379694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled, double-blind, multicentre clinical trial to investigate long-term tolerability and efficacy of trospium chloride in patients with detrusor instability.
    Halaska M; Ralph G; Wiedemann A; Primus G; Ballering-Brühl B; Höfner K; Jonas U
    World J Urol; 2003 May; 20(6):392-9. PubMed ID: 12811500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Topical administration of oxybutynin hydrochloride in women with urge incontinence. Results of a prospective randomized double-blind study].
    Enzelsberger H; Kurz C; Helmer H; Mittermayer F
    Geburtshilfe Frauenheilkd; 1995 May; 55(5):240-3. PubMed ID: 7607378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should we switch over to tolterodine in every child with non-neurogenic daytime urinary incontinence in whom oxybutynin failed?
    Yucel S; Akkaya E; Guntekin E; Kukul E; Danisman A; Akman S; Baykara M
    Urology; 2005 Feb; 65(2):369-73. PubMed ID: 15708055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of four anticholinesterase-anticholinergic combinations and tracheal extubation on QTc interval of the ECG, heart rate and arterial pressure.
    Saarnivaara L; Simola M
    Acta Anaesthesiol Scand; 1998 Apr; 42(4):460-3. PubMed ID: 9563867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of NS-21, an anticholinergic drug with calcium antagonistic activity, on lower urinary tract function in a rat model of urinary frequency.
    Sasaki Y; Hamada K; Yamazaki C; Seto T; Kimura Y; Ukai Y; Yoshikuni Y; Kimura K
    Int J Urol; 1997 Jul; 4(4):401-6. PubMed ID: 9256331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of overactive bladder in a difficult-to-treat patient with a transdermal formulation of oxybutynin.
    Saltzstein L
    Urol Nurs; 2005 Aug; 25(4):260-2. PubMed ID: 16225342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Literature review and pilot studies of the effect of QT correction formulas on reported beta2-agonist-induced QTc prolongation.
    Milic M; Bao X; Rizos D; Liu F; Ziegler MG
    Clin Ther; 2006 Apr; 28(4):582-90. PubMed ID: 16750469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.